Coca-Cola Hellenic Bottling Company or simply Coca-Cola HBC withdrew its beverages in Croatia while the officials are investigating mysterious illnesses that are suspected to have been caused by the products.
According to Reuters, the state inspection office in the region ordered the Coca-Cola HBC bottling company to take back some batches of two soft drinks brands. On Wednesday, Nov. 8, the officials asked the Croatian unit of the Coca-Cola Company to stop the sake of the specified products as well.
Coca-Cola to Comply With the Order
Coca-Cola HBC which distributes the brand’s products in the country released a statement following the order from the inspection office. In the note that was published by local media, the company said it carried out an internal check but did not find any irregularities in its drinks, the Irish Independent reported.
The Coke maker said that despite its findings, it would still follow the order and withdraw the batches until the state’s probe is completed.
What Sparked the Probe on Coca-Cola’s Soft Drinks
Based on the reports, an investigation was carried out after a young man from the town of Rijeka suddenly complained of throat injuries after drinking a flavored Coca-Cola mineral drink in a cafe. He was immediately brought to the hospital and while still being treated, six more individuals with suspected similar cases showed up in other locations which are the towns of Varazdin and Zagreb.
The country’s health minister, Vili Beros, confirmed the cases of all the individuals. He said that all have been examined in a medical facility but most of them were already sent home.
Finally, the health official said they did not find a direct connection with the cases yet and analysis of drink samples is still ongoing but they expect to get the results soon. The products that were temporarily withdrawn by Coca-Cola HBC Croatia are one batch of Coca-Cola Original Taste in 500 ml. bottles and two batches of Romerquelle Emotion Blueberry Pomegranate in 330 ml. containers.
Photo by: Steve Buissinne/Pixabay


FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Goldman Sachs Offers Hedge Funds Tools to Short AI-Threatened Corporate Loans
Jens Erik Gould of Amalga Group on Why Managed Delivery Is Replacing Staff Augmentation in Nearshore Outsourcing
Domino's Pizza UK Reports 15% Drop in Annual Profit Amid Weak Sales and Rising Costs
Lindt Posts Record CHF 5.92 Billion in Sales for 2025, Doubles Share Buyback Program
BYD Launches Next-Generation Blade Battery With 1,000 km Range as EV Competition Intensifies
Shell Signs Oil and Gas Agreements With Venezuela to Advance Dragon Gas Project
Chinese Electric Freight Trucks Are Disrupting Europe's Market in 2026
Inspire Brands IPO Could Raise $2 Billion as Roark Capital Explores Public Listing
Nvidia Sets $4M CEO Bonus Target for Fiscal 2027 as AI Demand Drives Revenue Growth
Apple Bets Big on India: iPhone Production Hits 55 Million Units as China Reliance Fades
FAA Issues Ground Stop for JetBlue Airways Flights Across All Destinations
SoftBank Seeks Up to $40 Billion Loan to Fund Major Investment in OpenAI
Tanzania’s economy: Strong Foundations, Positive Indicators
Air New Zealand Raises Fares as Middle East Conflict Drives Jet Fuel Prices Higher
Trump Administration Proposes Tough AI Contract Rules as Anthropic Blacklisted by Pentagon
Wizz Air Receives Tentative U.S. Approval for UK–U.S. Flights Amid Rising Travel Demand 



